يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Daniela Bertens"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Amsterdam Neuroscience - Neurodegeneration, Neurology, Radiology and nuclear medicine, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Psychiatrie & Neuropsychologie, School of Medicine / Clinical Medicine

    المصدر: The Lancet Neurology, 16(12), 965-975. Lancet Publishing Group
    The Lancet. Neurology
    Lancet Neurology, 16(12), 965-975. Elsevier Science
    Soininen, H, Solomon, A, Visser, P J, Hendrix, S B, Blennow, K, Kivipelto, M, Hartmann, T & LipiDiDiet clinical study group 2017, ' 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet) : a randomised, double-blind, controlled trial ', The Lancet Neurology, vol. 16, no. 12, pp. 965-975 . https://doi.org/10.1016/S1474-4422(17)30332-0

  3. 3
  4. 4

    المساهمون: Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Neurology, Amsterdam Neuroscience - Neurodegeneration

    المصدر: Alzheimer's Research & Therapy, 11(1):74. BioMed Central Ltd
    Bertens, D, Vos, S, Kehoe, P, Wolf, H, Nobili, F, Mendonça, A, van Rossum, I, Hort, J, Molinuevo, J L, Heneka, M, Petersen, R, Scheltens, P & Visser, P J 2019, ' Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: A European survey ', Alzheimer's Research and Therapy, vol. 11, no. 1, 74 . https://doi.org/10.1186/s13195-019-0525-9
    Alzheimer's Research and Therapy, 11(1):74. BioMed Central
    Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2019)
    Bertens, D, Vos, S, Kehoe, P, Wolf, H, Nobili, F, Mendonça, A, van Rossum, I, Hort, J, Molinuevo, J L, Heneka, M, Petersen, R, Scheltens, P & Visser, P J 2019, ' Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care : a European survey ', Alzheimer's Research and Therapy, vol. 11, 74 (2019) . https://doi.org/10.1186/s13195-019-0525-9
    Alzheimer's Research & Therapy
    Alzheimer's research & therapy 11(1), 74 (2019). doi:10.1186/s13195-019-0525-9

    وصف الملف: application/pdf

  5. 5

    المساهمون: RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Psychiatrie & Neuropsychologie, Neurology, Amsterdam Neuroscience - Neurodegeneration, Laboratory Medicine

    المصدر: Alzheimer's Research & Therapy, 9:8. BioMed Central Ltd
    Alzheimer's Research and Therapy, 9(1):8. BioMed Central
    Alzheimer's Research & Therapy
    Bertens, D, Tijms, B M, Scheltens, P, Teunissen, C E & Visser, P J 2017, ' Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population ', Alzheimer's Research and Therapy, vol. 9, no. 1, 8 . https://doi.org/10.1186/s13195-016-0233-7

  6. 6
  7. 7
  8. 8
  9. 9

    المساهمون: Neuroscience Campus Amsterdam - Neurodegeneration, Neurology, Epidemiology and Data Science, NCA - neurodegeneration, Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience

    المصدر: Alzheimers & Dementia, 11(5), 511-522. Elsevier Inc.
    Alzheimers & Dementia, 11(5), 511-522. Elsevier
    Alzheimer's & Dementia, 11(5), 511-522. Elsevier Science
    Bertens, D, Knol, D L, Scheltens, P & Visser, P J 2015, ' Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease ', Alzheimers & Dementia, vol. 11, no. 5, pp. 511-522 . https://doi.org/10.1016/j.jalz.2014.05.1754

  10. 10